Novel IRAK Degraders for Treating Cancer.
Rachel MataPublished in: ACS medicinal chemistry letters (2022)
Provided herein are novel compounds used as IRAK4 degraders, their pharmaceutical compositions, the use of such compounds in treating cancer, and processes for preparing such compounds.